Literature DB >> 27061568

A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients.

A C Chen1,2, A J Martin3, R A Dalziell1, C A McKenzie4, P M Lowe2,5, J M Eris2,6, R A Scolyer2,4,7, H M Dhillon8, J L Vardy8,9,10, V A Bielski6, G M Halliday1,2, D L Damian11,12,13.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27061568     DOI： 10.1111/bjd.14662

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  17 in total

Review 1.  Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients.

Authors:  M Blomberg; S Y He; C Harwood; S T Arron; S Demehri; A Green; M M Asgari
Journal:  Br J Dermatol       Date:  2017-10-30       Impact factor: 9.302

Review 2.  Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.

Authors:  Joanne M Jeter; Tawnya L Bowles; Clara Curiel-Lewandrowski; Susan M Swetter; Fabian V Filipp; Zalfa A Abdel-Malek; Larisa J Geskin; Jerry D Brewer; Jack L Arbiser; Jeffrey E Gershenwald; Emily Y Chu; John M Kirkwood; Neil F Box; Pauline Funchain; David E Fisher; Kari L Kendra; Ashfaq A Marghoob; Suephy C Chen; Michael E Ming; Mark R Albertini; John T Vetto; Kim A Margolin; Sherry L Pagoto; Jennifer L Hay; Douglas Grossman; Darrel L Ellis; Mohammed Kashani-Sabet; Aaron R Mangold; Svetomir N Markovic; Frank L Meyskens; Kelly C Nelson; Jennifer G Powers; June K Robinson; Debjani Sahni; Aleksandar Sekulic; Vernon K Sondak; Maria L Wei; Jonathan S Zager; Robert P Dellavalle; John A Thompson; Martin A Weinstock; Sancy A Leachman; Pamela B Cassidy
Journal:  Cancer       Date:  2018-10-03       Impact factor: 6.860

Review 3.  Keratinocyte Carcinomas: Current Concepts and Future Research Priorities.

Authors:  Priyadharsini Nagarajan; Maryam M Asgari; Adele C Green; Samantha M Guhan; Sarah T Arron; Charlotte M Proby; Dana E Rollison; Catherine A Harwood; Amanda Ewart Toland
Journal:  Clin Cancer Res       Date:  2018-12-06       Impact factor: 12.531

Review 4.  De Novo Malignancies after Kidney Transplantation.

Authors:  David Al-Adra; Talal Al-Qaoud; Kevin Fowler; Germaine Wong
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-29       Impact factor: 8.237

Review 5.  Oral nicotinamide for non-melanoma skin cancers: A review.

Authors:  Samantha Vicki Hunt; Aaron Jamison; Raman Malhotra
Journal:  Eye (Lond)       Date:  2022-03-28       Impact factor: 4.456

Review 6.  Cutaneous squamous cell carcinoma in the organ transplant recipient.

Authors:  Kristin Bibee; Andrew Swartz; Shaum Sridharan; Cornelius H L Kurten; Charles B Wessel; Heath Skinner; Dan P Zandberg
Journal:  Oral Oncol       Date:  2020-02-14       Impact factor: 5.337

7.  Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression-associated keratinocyte carcinoma.

Authors:  C A Harwood; S T Arron; C M Proby; M M Asgari; J N Bouwes Bavinck; A C Green; A E Toland
Journal:  Br J Dermatol       Date:  2017-11       Impact factor: 9.302

Review 8.  Xeroderma pigmentosum: an updated review.

Authors:  Alexander Kc Leung; Benjamin Barankin; Joseph M Lam; Kin Fon Leong; Kam Lun Hon
Journal:  Drugs Context       Date:  2022-04-25

Review 9.  Investigative Landscape in Advanced Non-Melanoma Skin Cancers.

Authors:  Priyanka Reddy; Min Yao; Monaliben Patel
Journal:  Curr Treat Options Oncol       Date:  2021-06-07

Review 10.  Evolving concepts in NAD+ metabolism.

Authors:  Claudia C S Chini; Julianna D Zeidler; Sonu Kashyap; Gina Warner; Eduardo Nunes Chini
Journal:  Cell Metab       Date:  2021-04-29       Impact factor: 31.373
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.